Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CD73-generated extracellular adenosine promotes resolution of neutrophil-mediated tissue injury and restrains metaplasia in pancreatitis.
FASEB J. 2023 Jan;37(1):e22684. doi: 10.1096/fj.202201537R.
FASEB J. 2023.
PMID: 36468677
Free PMC article.
Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma.
Faraoni EY, Strickland LN, O'Brien BJ, Barraza JF, Thosani NC, Wray CJ, Mills TW, Bailey-Lundberg JM.
Faraoni EY, et al. Among authors: strickland ln.
Front Oncol. 2022 Sep 6;12:995027. doi: 10.3389/fonc.2022.995027. eCollection 2022.
Front Oncol. 2022.
PMID: 36147911
Free PMC article.
Item in Clipboard
Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer.
Faraoni EY, O'Brien BJ, Strickland LN, Osborn BK, Mota V, Chaney J, Atkins CL, Cen P, Rowe J, Cardenas J, Poulsen KL, Wray CJ, Thosani NC, Bailey-Lundberg JM.
Faraoni EY, et al. Among authors: strickland ln.
Cancer Immunol Res. 2023 Jan 3;11(1):4-12. doi: 10.1158/2326-6066.CIR-22-0379.
Cancer Immunol Res. 2023.
PMID: 36367967
Free PMC article.
Item in Clipboard
CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
Faraoni EY, Singh K, Chandra V, Le Roux O, Dai Y, Sahin I, O'Brien BJ, Strickland LN, Li L, Vucic E, Warner AN, Pruski M, Clark T, Van Buren G, Thosani NC, Bynon JS, Wray CJ, Bar-Sagi D, Poulsen KL, Vornik LA, Savage MI, Sei S, Mohammed A, Zhao Z, Brown PH, Mills T, Eltzschig HK, McAllister F, Bailey-Lundberg JM.
Faraoni EY, et al. Among authors: strickland ln.
Cancer Res. 2023 Apr 4;83(7):1111-1127. doi: 10.1158/0008-5472.CAN-22-2553.
Cancer Res. 2023.
PMID: 36720042
Free PMC article.
Item in Clipboard
The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
Strickland LN, Faraoni EY, Ruan W, Yuan X, Eltzschig HK, Bailey-Lundberg JM.
Strickland LN, et al.
Front Immunol. 2023 Apr 28;14:1163585. doi: 10.3389/fimmu.2023.1163585. eCollection 2023.
Front Immunol. 2023.
PMID: 37187740
Free PMC article.
Review.
Item in Clipboard
Cite
Cite